|
Delayed
NYSE
23:48:56 30/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.150 USD | +0.88% |
|
-2.54% | -15.44% |
| 08-15 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 08-15 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.88% | -2.54% | +12.75% | +17.35% | -15.44% | -28.12% | -79.46% | -87.02% | -97.16% | 35.84M | |
| +4.16% | -0.30% | +6.32% | +32.63% | +84.62% | +58.96% | +94.17% | +11.49% | - | 71.53B | |
| -0.19% | -1.01% | -5.41% | +7.82% | +18.14% | +38.55% | +83.85% | +232.47% | +5,478.39% | 60.12B | |
| -1.51% | +2.20% | -1.47% | +6.60% | +6.95% | +10.66% | +35.15% | -17.45% | +211.42% | 48.85B | |
| -0.02% | +0.44% | +3.01% | +39.24% | +19.36% | +41.64% | +38.77% | +12.32% | +231.90% | 44.28B | |
| +0.47% | +8.29% | +0.48% | +10.29% | +159.33% | +342.31% | +689.30% | +650.85% | - | 43.83B | |
| +0.26% | +0.43% | +1.95% | +28.64% | +20.66% | +7.60% | +105.37% | +0.99% | +1,089.81% | 41.53B | |
| -0.67% | -0.45% | -6.82% | -0.84% | +3.09% | +4.47% | +46.37% | -17.19% | +134.15% | 30.13B | |
| +4.77% | +6.46% | +10.66% | +58.87% | +78.28% | +41.54% | +22.78% | -55.45% | - | 27.98B | |
| -1.33% | -2.98% | -5.75% | +7.68% | -34.03% | -20.28% | +352.54% | +316.88% | +690.70% | 25.25B | |
| -0.04% | +0.39% | -2.73% | +6.22% | +3.82% | +0.22% | -12.34% | -63.79% | - | 24.76B | |
| +1.12% | +2.23% | +10.41% | +30.53% | +15.59% | +21.56% | -4.13% | -16.59% | +107.35% | 20.99B | |
| +0.28% | +0.70% | +4.62% | +17.34% | +10.65% | +20.87% | +156.20% | +228.32% | +1,981.18% | 17.36B | |
| +1.67% | +4.74% | -21.36% | +6.12% | +186.76% | +163.24% | +345.14% | +1,419.98% | +651.59% | 15.54B | |
| -1.57% | -5.02% | +3.65% | +10.00% | +20.19% | +23.36% | +40.19% | -32.19% | +85.57% | 14.99B | |
| -0.05% | +2.46% | -13.08% | -14.28% | - | - | - | - | - | 14.98B | |
| -0.62% | +7.69% | +30.82% | +42.38% | +39.68% | +2.19% | - | - | - | 14.9B | |
| -0.38% | +3.19% | +7.14% | +7.59% | +33.56% | +41.74% | +163.46% | +176.92% | +357.70% | 14.53B | |
| +2.96% | -0.65% | -5.34% | +11.80% | +24.17% | -1.74% | +535.77% | - | - | 14.41B | |
| -0.15% | +6.51% | +2.48% | +30.25% | +48.08% | +88.80% | +52.75% | -28.42% | +254.45% | 14.13B | |
| Average | +0.58% | +0.31% | +1.62% | +17.81% | +38.08% | +45.14% | +148.10% | +160.71% | +859.77% | 28.01B | |
| Weighted average by Cap. | +0.76% | +0.51% | +0.92% | +19.26% | +43.15% | +56.09% | +150.60% | +144.96% | +1,361.83% |
- Stock Market
- Stocks
- ATNM Stock
- Sector Actinium Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
